Signaling pathways and mesenchymal transition in pediatric high-grade glioma

[1]  L. Cerchia,et al.  PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas , 2019, Cancers.

[2]  T. Peterson,et al.  Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells , 2019, PloS one.

[3]  Adré Marshall.  Invasion , 2018, Best "New" African Poets 2018 Anthology.

[4]  J. Koster,et al.  Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies , 2017, Experimental cell research.

[5]  K. Ligon,et al.  Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Ruge,et al.  Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. , 2017, Journal of neurosurgery. Pediatrics.

[7]  E. Sánchez,et al.  External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry , 2017, Journal of Neuro-Oncology.

[8]  Meng Li,et al.  Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma. , 2017, Cancer cell.

[9]  C. Kramm,et al.  Snail homolog 1 is involved in epithelial-mesenchymal transition-like processes in human glioblastoma cells. , 2017, Oncology letters.

[10]  Rachel N. Rattenni,et al.  Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas. , 2017, The American journal of pathology.

[11]  S. Yamada,et al.  Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma. , 2017, International Journal of Oncology.

[12]  K. Carraway,et al.  Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination , 2017, Oncogene.

[13]  F. Di Meco,et al.  Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells. , 2017, Cancer research.

[14]  Ning Liu,et al.  Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth , 2016, Cell.

[15]  S. Pfister,et al.  The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner , 2016, Oncotarget.

[16]  A. Jimeno,et al.  Emerging from their burrow: Hedgehog pathway inhibitors for cancer , 2016, Expert opinion on investigational drugs.

[17]  Jon R. Wilson,et al.  Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2 , 2016, Nature Communications.

[18]  Keith L. Ligon,et al.  Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma , 2016, Nature Communications.

[19]  I. Nakano,et al.  SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial–mesenchymal transition and invasion in mice and humans , 2016, Oncogene.

[20]  D. Brat,et al.  Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. , 2016, Neuro-oncology.

[21]  A. Sica,et al.  Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies , 2016, Oncogene.

[22]  M. Hegi,et al.  WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1 , 2016, Oncogene.

[23]  Kun Xu,et al.  Retraction Note to: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma , 2015, Molecular Neurobiology.

[24]  Y. Suh,et al.  Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. , 2015, Pathology, research and practice.

[25]  Kun Xu,et al.  RETRACTED ARTICLE: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma , 2015, Molecular Neurobiology.

[26]  C. Eberhart,et al.  ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres , 2015, Brain pathology.

[27]  S. Babashah,et al.  Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. , 2015, European journal of cancer.

[28]  C. Eberhart,et al.  Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition , 2015, Journal of neuropathology and experimental neurology.

[29]  A. Truong,et al.  Targeted Therapy for MAPK Alterations in Pediatric Gliomas , 2015, Brain disorders & therapy.

[30]  T. Ay,et al.  Targeted Therapy for MAPK Alterations in Pediatric Gliomas. , 2015 .

[31]  M. Nykter,et al.  Twist predicts poor outcome of patients with astrocytic glioma , 2015, Journal of Clinical Pathology.

[32]  M. Millward,et al.  Secreted Frizzled-Related Protein 4 Inhibits Glioma Stem-Like Cells by Reversing Epithelial to Mesenchymal Transition, Inducing Apoptosis and Decreasing Cancer Stem Cell Properties , 2015, PloS one.

[33]  Ki-Chun Yoo,et al.  Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer , 2015, Cancer science.

[34]  Y. Xiong,et al.  The 14-3-3σ/GSK3β/β-catenin/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer , 2015, Oncotarget.

[35]  G. Pilkington,et al.  Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells , 2015, Oncotarget.

[36]  H. Mehdorn,et al.  Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1 , 2015, Oncotarget.

[37]  Zhaoming Li,et al.  Six1 promotes glioblastoma cell proliferation and invasion by upregulation of connective tissue growth factor. , 2015, American journal of cancer research.

[38]  Xuqi Li,et al.  Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer , 2015, Tumor Biology.

[39]  Bino John,et al.  Genome-Wide Transcript Profiling Reveals Novel Breast Cancer-Associated Intronic Sense RNAs , 2015, PloS one.

[40]  A. Moon,et al.  Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H‐Ras‐induced epithelial to mesenchymal transition , 2015, International journal of cancer.

[41]  Jun Du,et al.  EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells , 2015, Oncotarget.

[42]  H. Huber,et al.  Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma , 2015, Hepatology.

[43]  S. Ren,et al.  High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients. , 2015, International journal of clinical and experimental pathology.

[44]  R. Reis,et al.  AXL as a modulator of sunitinib response in glioblastoma cell lines. , 2015, Experimental cell research.

[45]  E. Choi,et al.  Compromised MAPK signaling in human diseases: an update , 2015, Archives of Toxicology.

[46]  Michael A. Durante,et al.  Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation , 2015, Oncogene.

[47]  Ming-hua Bai,et al.  Silencing of HIF-1α enhances the radiation sensitivity of human glioma growth in vitro and in vivo , 2015, Neuropharmacology.

[48]  Ziwei Wang,et al.  Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway. , 2015, Cancer letters.

[49]  C. Sze,et al.  Modulation of Sonic hedgehog signaling and WW domain containing oxidoreductase WOX1 expression enhances radiosensitivity of human glioblastoma cells , 2015, Experimental biology and medicine.

[50]  Q. Shi,et al.  Β-catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition. , 2015, Biochemical and biophysical research communications.

[51]  H. Duffau,et al.  Notch1 Stimulation Induces a Vascularization Switch With Pericyte‐Like Cell Differentiation of Glioblastoma Stem Cells , 2015, Stem cells.

[52]  David T. W. Jones,et al.  WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma , 2014, Acta neuropathologica communications.

[53]  C. Allis,et al.  Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation , 2014, Science.

[54]  G. Maira,et al.  PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment , 2014, Molecular Cancer.

[55]  Young Yang,et al.  N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling. , 2014, Cancer letters.

[56]  Ying-jian Liang,et al.  FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling , 2014, BMC Cancer.

[57]  Gabriele Schackert,et al.  Molecular characterization of long‐term survivors of glioblastoma using genome‐ and transcriptome‐wide profiling , 2014, International journal of cancer.

[58]  David T. W. Jones,et al.  Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. , 2014, Neuro-oncology.

[59]  Chris Jones,et al.  Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma , 2014, Nature Reviews Cancer.

[60]  Janfeng Wang,et al.  The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma. , 2014, International journal of clinical and experimental pathology.

[61]  Jun Du,et al.  Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells , 2014, Cell and Tissue Research.

[62]  Hae-Yun Jung,et al.  Molecular Pathways: Linking Tumor Microenvironment to Epithelial–Mesenchymal Transition in Metastasis , 2014, Clinical Cancer Research.

[63]  I. Mackenzie,et al.  The receptor tyrosine kinase Axl regulates cell–cell adhesion and stemness in cutaneous squamous cell carcinoma , 2014, Oncogene.

[64]  A. Bullock,et al.  Structure–Activity Relationship of 3,5-Diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants , 2014, Journal of medicinal chemistry.

[65]  B. Bonavida,et al.  Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention , 2014, Journal of experimental & clinical cancer research : CR.

[66]  E. Llamosas,et al.  The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. , 2014, Gynecologic oncology.

[67]  L. Norton,et al.  N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties , 2014, Oncogene.

[68]  Peng Zhang,et al.  Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway , 2014, The Journal of pathology.

[69]  K. Creek,et al.  Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes. , 2014, Carcinogenesis.

[70]  Joseph Rosenbluh,et al.  KRAS and YAP1 Converge to Regulate EMT and Tumor Survival , 2014, Cell.

[71]  P. Malatesta,et al.  A cadherin switch underlies malignancy in high-grade gliomas , 2014, Oncogene.

[72]  Jianping Zhang,et al.  HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT , 2014, Tumor Biology.

[73]  Yizhi Liu,et al.  The Complex Interplay between ERK1/2, TGFβ/Smad, and Jagged/Notch Signaling Pathways in the Regulation of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelium Cells , 2014, PloS one.

[74]  X. Chen,et al.  Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells. , 2014, Current molecular medicine.

[75]  H. Shirato,et al.  Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. , 2014, Neuro-oncology.

[76]  K. Jeong,et al.  A ROS/STAT3/HIF‐1α signaling cascade mediates EGF‐induced TWIST1 expression and prostate cancer cell invasion , 2014, The Prostate.

[77]  X. Chen,et al.  Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer , 2014, Cell Death and Disease.

[78]  Stephen Yip,et al.  Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma , 2014, Nature Genetics.

[79]  Liliana Goumnerova,et al.  Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma , 2014, Nature Genetics.

[80]  Amar Gajjar,et al.  The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma , 2014, Nature Genetics.

[81]  Y. Jeng,et al.  Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma. , 2014, Carcinogenesis.

[82]  C. Kang,et al.  A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo. , 2014, Oncology reports.

[83]  K. Arita,et al.  Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining , 2014, Brain Tumor Pathology.

[84]  B. Wang,et al.  Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-κB pathway , 2014, Journal of Molecular Histology.

[85]  B. Zhou,et al.  Epigenetic regulation of EMT: the Snail story. , 2014, Current pharmaceutical design.

[86]  Michael Brudno,et al.  Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations , 2014, Nature Genetics.

[87]  A. Pierce,et al.  MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme , 2014, Oncotarget.

[88]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[89]  E. Aronica,et al.  Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. , 2014, Neuro-oncology.

[90]  Zhaoming Li,et al.  Targeting Six1 by lentivirus-mediated RNA interference inhibits colorectal cancer cell growth and invasion. , 2014, International journal of clinical and experimental pathology.

[91]  I. Kim,et al.  Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases , 2014, BMC Cancer.

[92]  M. Millward,et al.  Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells. , 2014, Oncology research.

[93]  Hao Wang,et al.  Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway. , 2014, European journal of pharmacology.

[94]  J. Vadgama,et al.  STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits , 2013, International journal of oncology.

[95]  L. Miele,et al.  Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. , 2013, Cancer letters.

[96]  H. Hermeking,et al.  SNAIL and miR‐34a feed‐forward regulation of ZNF281/ZBP99 promotes epithelial–mesenchymal transition , 2013, The EMBO journal.

[97]  B. Zhou,et al.  The Role of Snail in EMT and Tumorigenesis. , 2013, Current cancer drug targets.

[98]  M. Salto‐Tellez,et al.  AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer , 2013, Clinical Cancer Research.

[99]  Jing Zhang,et al.  Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells , 2013, BMC Cancer.

[100]  D. McDonald,et al.  Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia , 2013, Oncogene.

[101]  J. Shao,et al.  Suppressing the malignant phenotypes of glioma cells by lentiviral delivery of small hairpin RNA targeting hypoxia-inducible factor-1α. , 2013, International journal of clinical and experimental pathology.

[102]  T. Ryken,et al.  NOTCH3 Is a Prognostic Factor That Promotes Glioma Cell Proliferation, Migration and Invasion via Activation of CCND1 and EGFR , 2013, PloS one.

[103]  H. Ford,et al.  Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. , 2013, Cancer research.

[104]  Yong Li,et al.  Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance , 2013, Cell Death and Disease.

[105]  Y. Kudo,et al.  The FGFR1 inhibitor PD173074 induces mesenchymal–epithelial transition through the transcription factor AP-1 , 2013, British Journal of Cancer.

[106]  Chen Huang,et al.  Hypoxia-Induced Snail Expression Through Transcriptional Regulation by HIF-1α in Pancreatic Cancer Cells , 2013, Digestive Diseases and Sciences.

[107]  T. Tan,et al.  EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway , 2013, PloS one.

[108]  Miles A. Miller,et al.  The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells , 2013, Science Signaling.

[109]  D. Steindler,et al.  The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance , 2013, EMBO molecular medicine.

[110]  Mahlon D. Johnson,et al.  Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes. , 2013, Cell reports.

[111]  T. Merchant,et al.  Children's Oncology Group's 2013 blueprint for research: Central nervous system tumors , 2013, Pediatric blood & cancer.

[112]  S. Shankar,et al.  NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. , 2013, Neuro-oncology.

[113]  B. Garcia,et al.  Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.

[114]  H. Poulsen,et al.  Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures , 2013, Cancer biology & therapy.

[115]  Yongmei Song,et al.  The Expressions of Wnt/β-catenin Pathway-Related Components in Brainstem Gliomas , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[116]  A. Shiras,et al.  Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma , 2013, Molecular and Cellular Neuroscience.

[117]  Qi Zhang,et al.  Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. , 2013, Carcinogenesis.

[118]  Ziwei Wang,et al.  Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-β, and E-cadherin expression in gastric carcinoma , 2013, Contemporary oncology.

[119]  G. Basso,et al.  Wnt activation promotes neuronal differentiation of Glioblastoma , 2013, Cell Death and Disease.

[120]  C. Heldin,et al.  Snail depletes the tumorigenic potential of glioblastoma , 2013, Oncogene.

[121]  D. Radisky,et al.  AXL induces epithelial to mesenchymal transition and regulates the function of breast cancer stem cells , 2013, Oncogene.

[122]  Y. Chen,et al.  Effect of silencing HIF-1α on proliferation, invasion and migration of glioblastoma U87 cells , 2013, Neurological Sciences.

[123]  Ge Zhang,et al.  Epithelial–Mesenchymal Transition (EMT) Induced by TNF-α Requires AKT/GSK-3β-Mediated Stabilization of Snail in Colorectal Cancer , 2013, PloS one.

[124]  Gareth Browne,et al.  ZEB/miR‐200 feedback loop: At the crossroads of signal transduction in cancer , 2013, International journal of cancer.

[125]  A. Merlo,et al.  Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme , 2013, Oncogene.

[126]  Yongmei Song,et al.  Expression of β-catenin and E- and N-cadherin in human brainstem gliomas and clinicopathological correlations , 2013, The International journal of neuroscience.

[127]  G. Basso,et al.  Wnt activation promotes neuronal differentiation of Glioblastoma , 2013, Cell Death and Disease.

[128]  Xiao-ming Meng,et al.  Role of the TGF-β/BMP-7/Smad pathways in renal diseases. , 2013, Clinical science.

[129]  Y. Shang,et al.  Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. , 2013, Experimental cell research.

[130]  Miqin Zhang,et al.  Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β‐catenin , 2013, The journal of gene medicine.

[131]  G. Nikkhah,et al.  Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. , 2012, Cancer letters.

[132]  Jin Zeng,et al.  PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. , 2012, Cellular signalling.

[133]  J. Inazawa,et al.  SIX1 promotes epithelial–mesenchymal transition in colorectal cancer through ZEB1 activation , 2012, Oncogene.

[134]  C. Gondi,et al.  Glioma stem cell invasion through regulation of the interconnected ERK, integrin α6 and N-cadherin signaling pathway. , 2012, Cellular signalling.

[135]  Michael Peyton,et al.  An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.

[136]  David T. W. Jones,et al.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.

[137]  D. Zagzag,et al.  Mechanisms of glioma-associated neovascularization. , 2012, The American journal of pathology.

[138]  S. Weiss,et al.  Canonical Wnt signaling regulates Slug activity and links epithelial–mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression , 2012, Proceedings of the National Academy of Sciences.

[139]  A. Pierce,et al.  Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology , 2012, Oncogene.

[140]  J. Casal,et al.  Akt2 interacts with Snail1 in the E-cadherin promoter , 2012, Oncogene.

[141]  R. Ballotti,et al.  The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion , 2012, PloS one.

[142]  H. Ford,et al.  Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways , 2012, Breast Cancer Research.

[143]  Hao Wang,et al.  ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma , 2012, PloS one.

[144]  Jae Cheol Lee,et al.  Activation of the AXL Kinase Causes Resistance to EGFR-Targeted Therapy in Lung Cancer , 2012, Nature Genetics.

[145]  David T. W. Jones,et al.  K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas , 2012, Acta Neuropathologica.

[146]  Chi Wang,et al.  Interaction with Suv39H1 is Critical for Snail-mediated E-cadherin Repression in Breast Cancer , 2012, Oncogene.

[147]  S. Kohsaka,et al.  STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression , 2012, Molecular Cancer Therapeutics.

[148]  L. Macconaill,et al.  Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma , 2012, Pediatric blood & cancer.

[149]  Weiling Zhao,et al.  ERK/GSK3β/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition. , 2012, Free radical biology & medicine.

[150]  Do-Hyun Nam,et al.  Wnt activation is implicated in glioblastoma radioresistance , 2012, Laboratory Investigation.

[151]  C. Rüegg,et al.  Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes. , 2012, Cancer discovery.

[152]  P. Varlet,et al.  Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas , 2012, PloS one.

[153]  L. Tran,et al.  Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. , 2012, Cancer research.

[154]  J. Blenis,et al.  Down-regulation of CMTM8 Induces Epithelial-to-Mesenchymal Transition-like Changes via c-MET/Extracellular Signal-regulated Kinase (ERK) Signaling* , 2012, The Journal of Biological Chemistry.

[155]  E. Kondo,et al.  Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway , 2012, British Journal of Cancer.

[156]  Tao Chen,et al.  Notch1 promotes glioma cell migration and invasion by stimulating β‐catenin and NF‐κB signaling via AKT activation , 2012, Cancer science.

[157]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[158]  Li Ding,et al.  Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.

[159]  Yun Cui,et al.  Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition* , 2011, The Journal of Biological Chemistry.

[160]  A. Rustgi,et al.  Constitutive K-RasG12D Activation of ERK2 Specifically Regulates 3D Invasion of Human Pancreatic Cancer Cells via MMP-1 , 2011, Molecular Cancer Research.

[161]  D. Dinh,et al.  Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1 , 2011, Oncotarget.

[162]  J. Huse,et al.  Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas. , 2011, Cancer research.

[163]  S. Oh,et al.  Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. , 2011, Cancer research.

[164]  T. Jiang,et al.  Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways. , 2011, Oncology reports.

[165]  Barbara S. Paugh,et al.  Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[166]  S. Shirasawa,et al.  BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study , 2011, Molecular Cancer.

[167]  K. Nan,et al.  Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. , 2011, International journal of oncology.

[168]  M. Mimeault,et al.  Complex Oncogenic Signaling Networks Regulate Brain Tumor‐Initiating Cells and Their Progenies: Pivotal Roles of Wild‐Type EGFR, EGFRvIII Mutant and Hedgehog Cascades and Novel Multitargeted Therapies , 2011, Brain pathology.

[169]  P. Yue,et al.  Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells , 2011, Oncogene.

[170]  Hideo Nakamura,et al.  Essential role of the Hedgehog signaling pathway in human glioma‐initiating cells , 2011, Cancer science.

[171]  D. He,et al.  Knockdown of β-Catenin Through shRNA Cause a Reversal of EMT and Metastatic Phenotypes Induced by HIF-1α , 2011, Cancer investigation.

[172]  A. Satelli,et al.  Vimentin in cancer and its potential as a molecular target for cancer therapy , 2011, Cellular and Molecular Life Sciences.

[173]  Jun Qin,et al.  Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. , 2011, Cancer research.

[174]  Kai Huang,et al.  High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. , 2011, Neuro-oncology.

[175]  Xiaodong Jin,et al.  Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations , 2011, Clinical and Experimental Medicine.

[176]  Hongwei Zhang,et al.  miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3 , 2011, Molecular Cancer Research.

[177]  Lei Wang,et al.  β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells , 2011, Medical oncology.

[178]  J. Kim,et al.  Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas , 2011, Oncogene.

[179]  C. Miracco,et al.  β-catenin and Gli1 are prognostic markers in glioblastoma , 2011, Cancer biology & therapy.

[180]  J. Mpindi,et al.  Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer , 2011, Oncogene.

[181]  Wei Li,et al.  Notch1 expression is upregulated in glioma and is associated with tumor progression , 2011, Journal of Clinical Neuroscience.

[182]  I. Weissman,et al.  Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma , 2011, Proceedings of the National Academy of Sciences.

[183]  K. Arita,et al.  Wnt‐5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP‐2 , 2011, Cancer science.

[184]  R. Jope,et al.  The role of DDX3 in regulating Snail. , 2011, Biochimica et biophysica acta.

[185]  Y. Minami,et al.  Critical role of Wnt5a–Ror2 signaling in motility and invasiveness of carcinoma cells following Snail‐mediated epithelial–mesenchymal transition , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[186]  Fang Gao,et al.  Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells , 2011, BMC Cancer.

[187]  U. Cortes,et al.  STAT3 is essential for the maintenance of neurosphere‐initiating tumor cells in patients with glioblastomas: A potential for targeted therapy? , 2011, International journal of cancer.

[188]  M. Post,et al.  Mouse Snail Is a Target Gene for HIF , 2011, Molecular Cancer Research.

[189]  Sik Yoon,et al.  SNAI1 is Involved in the Proliferation and Migration of Glioblastoma Cells , 2011, Cellular and Molecular Neurobiology.

[190]  Tao Jiang,et al.  Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription , 2010, Brain Research.

[191]  Luigi Marchionni,et al.  The Notch Target Hes1 Directly Modulates Gli1 Expression and Hedgehog Signaling: A Potential Mechanism of Therapeutic Resistance , 2010, Clinical Cancer Research.

[192]  M. Bjørås,et al.  Mitochondrial DNA Integrity Is Essential For Mitochondrial Maturation During Differentiation of Neural Stem Cells , 2010, Stem cells.

[193]  H. Lo.  Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. , 2010, Current cancer drug targets.

[194]  C. Cohen,et al.  Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis , 2010, BMC nephrology.

[195]  S. Aaronson,et al.  Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. , 2010, Genes & development.

[196]  S. Chi,et al.  Activated STAT3 Regulates Hypoxia-Induced Angiogenesis and Cell Migration in Human Glioblastoma , 2010, Neurosurgery.

[197]  B. Necela,et al.  Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype , 2010, PloS one.

[198]  Jean-Yves Delattre,et al.  An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients , 2010, Molecular Cancer.

[199]  A. Ross,et al.  Cancer esearch apeutics , Targets , and Chemical Biology ecretase Inhibitors Enhance Temozolomide Treatment uman Gliomas by Inhibiting Neurosphere R opulation and Xenograft Recurrence , 2010 .

[200]  Y. Rao,et al.  Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells. , 2010, International journal of radiation oncology, biology, physics.

[201]  Richard G Grundy,et al.  Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[202]  Mark D. Johnson,et al.  SNAI2/Slug promotes growth and invasion in human gliomas , 2010, BMC Cancer.

[203]  Georgia Panagiotakos,et al.  Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate , 2010, Stem cells.

[204]  Li-ying Zhang,et al.  Reduced β-catenin Expression is Associated with Good Prognosis in Astrocytoma , 2010, Pathology & Oncology Research.

[205]  Jiri Zavadil,et al.  Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres , 2010, Molecular Cancer.

[206]  Zhiwei Wang,et al.  The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. , 2010, Current drug targets.

[207]  Y. Bevelacqua,et al.  The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit. , 2010, Genes & cancer.

[208]  A. Thorburn,et al.  Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity , 2010, Molecular Cancer Therapeutics.

[209]  K. Nakashiro,et al.  Conditional deletion of Stat3 promotes neurogenesis and inhibits astrogliogenesis in neural stem cells. , 2010, Biochemical and biophysical research communications.

[210]  Y. Hitoshi,et al.  R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. , 2010, Cancer research.

[211]  Bjørn Tore Gjertsen,et al.  Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival , 2009, Proceedings of the National Academy of Sciences.

[212]  C. Holterman,et al.  Human cancers converge at the HIF-2α oncogenic axis , 2009, Proceedings of the National Academy of Sciences.

[213]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[214]  J. Myung,et al.  Snail and Cox‐2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

[215]  B. Sullenger,et al.  Notch Promotes Radioresistance of Glioma Stem Cells , 2009, Stem cells.

[216]  Guido Nikkhah,et al.  NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts , 2009, Stem cells.

[217]  R. McLendon,et al.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype , 2009, Cell cycle.

[218]  A. Mahadevan,et al.  Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas , 2009, Neurochemistry International.

[219]  D. D. Billheimer,et al.  The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. , 2009, The Journal of clinical investigation.

[220]  H. Ford,et al.  Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[221]  M. Katoh,et al.  Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. , 2009, Current molecular medicine.

[222]  F. Vesuna,et al.  Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells , 2009, Oncogene.

[223]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[224]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[225]  Sabine Bahn,et al.  Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia , 2009, BMC Medical Genomics.

[226]  K. Camphausen,et al.  Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro , 2009, Molecular Cancer Research.

[227]  Simone Brabletz,et al.  E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer , 2009, Cancer and Metastasis Reviews.

[228]  L. Denaro,et al.  Hypoxia and HIF1α Repress the Differentiative Effects of BMPs in High‐Grade Glioma , 2009, Stem cells.

[229]  R. Puri,et al.  Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. , 2008, Neuro-oncology.

[230]  Y. Komiya,et al.  Wnt signal transduction pathways , 2008, Organogenesis.

[231]  K. Helin,et al.  A role for the transcription factor HEY1 in glioblastoma , 2008, Journal of cellular and molecular medicine.

[232]  I. Pollack,et al.  Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas , 2008, Journal of Neuro-Oncology.

[233]  Ki Wook Kim,et al.  Role of Wnt5a in the proliferation of human glioblastoma cells. , 2007, Cancer letters.

[234]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[235]  Sheng-Chieh Hsu,et al.  Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. , 2007, Cancer research.

[236]  T. Curran,et al.  Loss of suppressor-of-fused function promotes tumorigenesis , 2007, Oncogene.

[237]  M. Mullendore,et al.  Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. , 2007, Endocrine-related cancer.

[238]  Brian Keith,et al.  Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.

[239]  E. Hay,et al.  TGFβ3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex , 2007, Journal of Cell Science.

[240]  D. Gillespie,et al.  Silencing of Hypoxia Inducible Factor-1α by RNA Interference Attenuates Human Glioma Cell Growth In vivo , 2007, Clinical Cancer Research.

[241]  E. Fuchs,et al.  Catenins: keeping cells from getting their signals crossed. , 2006, Developmental cell.

[242]  E. Bernhard,et al.  Akt1 Activation Can Augment Hypoxia-Inducible Factor-1α Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin–Independent Pathway , 2006, Molecular Cancer Research.

[243]  M. Essig,et al.  Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[244]  S. Donaldson,et al.  Advances toward an understanding of brainstem gliomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[245]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[246]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[247]  L. Sommer,et al.  Wnt signaling: multiple functions in neural development , 2005, Cellular and Molecular Life Sciences CMLS.

[248]  N. Amariglio,et al.  Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. , 2005, Cancer research.

[249]  Mariann Bienz,et al.  β-Catenin: A Pivot between Cell Adhesion and Wnt Signalling , 2005, Current Biology.

[250]  A. G. de Herreros,et al.  Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription , 2005, The Journal of cell biology.

[251]  M. Hung,et al.  Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.

[252]  R. Puri,et al.  Analysis of interleukin‐13 receptor α2 expression in human pediatric brain tumors , 2004, Cancer.

[253]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[254]  D. Dressman,et al.  Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. , 2003, Cancer research.

[255]  Elaine Fuchs,et al.  Sticky Business Orchestrating Cellular Signals at Adherens Junctions , 2003, Cell.

[256]  L. Ericson,et al.  Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes , 2002, Journal of Cell Science.

[257]  Eduard Batlle,et al.  Snail Induction of Epithelial to Mesenchymal Transition in Tumor Cells Is Accompanied by MUC1 Repression andZEB1 Expression* , 2002, The Journal of Biological Chemistry.

[258]  P. Heinrich,et al.  Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited. , 2001, European journal of biochemistry.

[259]  R. Puri,et al.  In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. , 2001, Cancer research.

[260]  H. Moses,et al.  Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.

[261]  A. G. Herreros,et al.  The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.

[262]  N. Imamoto,et al.  beta-catenin can be transported into the nucleus in a Ran-unassisted manner. , 1999, Molecular biology of the cell.

[263]  M. Metzker,et al.  Cloning of a novel member of the low-density lipoprotein receptor family. , 1998, Gene.

[264]  E R Levy,et al.  Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. , 1998, Biochemical and biophysical research communications.

[265]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[266]  B. Gumbiner,et al.  Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin , 1998, Current Biology.

[267]  P. Adler,et al.  Tissue polarity points from cells that have higher Frizzled levels towards cells that have lower Frizzled levels , 1997, Current Biology.

[268]  Jörg Stappert,et al.  β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .

[269]  Jeremy Nathans,et al.  A new member of the frizzled family from Drosophila functions as a Wingless receptor , 1996, Nature.

[270]  Hugo J. Bellen,et al.  Notch Signaling , 2014, Methods in Molecular Biology.

[271]  M. Kieran,et al.  Identification of novel biologic targets in the treatment of newly diagnosed diffuse intrinsic pontine glioma. , 2012, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[272]  X. Zhi,et al.  Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma by increasing hif-1alpha activity and decreasing hypoxia-associated cell death , 2012 .

[273]  Lucila Ohno-Machado,et al.  Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. , 2011, Cancer research.

[274]  K. Nakayama,et al.  Loss of MKK4 expression in ovarian cancer: A potential role for the epithelial to mesenchymal transition , 2011, International journal of cancer.

[275]  A. Sonabend,et al.  Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD133+ Glioma Stem Cells to Temozolomide Therapy , 2011, Molecular medicine.

[276]  S. Eksborg,et al.  Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. , 2010, Cancer research.

[277]  J. Uhm,et al.  The transcriptional network for mesenchymal transformation of brain tumours , 2010 .

[278]  H. Hoefler,et al.  Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. , 2009, Frontiers in bioscience.

[279]  H. Earp,et al.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. , 2008, Advances in cancer research.

[280]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[281]  R. Nusse,et al.  WNT targets. Repression and activation. , 1999, Trends in genetics : TIG.

[282]  A. Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.